Udenyca Pegfilgrastim-cbqv Injection
Accord BioPharma is recalling Udenyca injection due to improper storage temperature conditions.
Contact your healthcare provider or pharmacist to determine if your medication is affected. Do not use the product if it was stored outside of the required refrigerated environment.
Recall at a glance
- Quantity recalled
- 116 cartons
Why it was recalled
Accord BioPharma is recalling specific units of Udenyca (pegfilgrastim-cbqv) injection due to temperature abuse. The affected products were stored in a controlled room temperature environment instead of the required refrigerated conditions.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
UDENYCA, pegfilgrastim-cbqv injection
- Strength
- 6 mg
- NDC / UPC
- NDC 69448-025-63
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other recent recalls from McKesson
Editorial summary by Recall Canary · summary updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification